Los Angeles-based Prospect Medical Holdings has reached a deal with two Pennsylvania stakeholders to halt active litigation and activate a 270-day window to sell its struggling Springfield, Pa.-based Crozer Health.
Legal & Regulatory Issues
Mark Schena, former president of medtech company Arrayit Corp., on Oct. 18 was sentenced to eight years in prison and ordered to pay $24 million in restitution for defrauding investors and paying illegal kickbacks that resulted in the submission of…
A former medical director of one of Seattle Children's clinics is suing the hospital alleging racial discrimination, The Seattle Times reported Oct. 18.
Brentwood, Tenn.-based Quorum Health acknowledged that it failed to provide compliance reports to the state of North Carolina for shuttered Martin General Hospital for five years, local news outlet WITN reported Oct. 18.
Two former employees of Baptist Memorial Hospital-Memphis admitted to stealing more than $175,000 worth of supplies from the hospital, according to Fox News affiliate WHBQ-TV.
Advertisement
The president and co-owner of a Connecticut nursing program that was shut down in February testified Oct. 16 in a class-action lawsuit filed by eight former Stone Academy students.
The Washington Hospital Association filed a lawsuit Oct. 16 against the state over the state's health department's change in interpretation of a long-standing charity care law. According to the lawsuit, hospitals statewide are required to provide charity care for any…
More than 100 plaintiffs have joined four separate lawsuits against Derrick Todd, MD, a former rheumatologist at Boston-based Brigham and Women's Hospital accused of performing inappropriate pelvic and breast exams on patients, The Boston Globe reported Oct. 16.
A Florida woman was charged with operating an assisted living facility without a license and organized scheme to defraud after she was allegedly found running a postoperative care company and using the license of a California nurse, ABC affiliate WPLG…
Mayo Clinic and Lifepoint Health are suing Bristol Myers Squibb and its subsidiary, Celgene, alleging the companies inflated the price of the cancer drug Revlimid by paying other drugmakers to keep their generic versions off the market, the San Francisco Business…